Krebs Biochemicals Industries reports standalone net loss of Rs 4.98 crore in the December 2023 quarter - Business Standard

KREBSBIO   104.14  8.79  7.78%   
Under 62% of Krebs Biochemicals' investor base is looking to short. The analysis of overall sentiment of trading Krebs Biochemicals and stock suggests that many investors are alarmed at this time. Krebs Biochemicals' investing sentiment shows overall attitude of investors towards Krebs Biochemicals and.
  
Krebs Biochemicals Industries reports standalone net loss of Rs 4.98 crore in the December 2023 quarter Business Standard

Read at news.google.com
Google News at Macroaxis
  

Krebs Biochemicals Fundamental Analysis

We analyze Krebs Biochemicals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Krebs Biochemicals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Krebs Biochemicals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Total Debt

Total Debt Comparative Analysis

Krebs Biochemicals is currently under evaluation in total debt category among its peers. Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

Krebs Biochemicals and Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Krebs Biochemicals stock to make a market-neutral strategy. Peer analysis of Krebs Biochemicals could also be used in its relative valuation, which is a method of valuing Krebs Biochemicals by comparing valuation metrics with similar companies.

Complementary Tools for Krebs Stock analysis

When running Krebs Biochemicals' price analysis, check to measure Krebs Biochemicals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Krebs Biochemicals is operating at the current time. Most of Krebs Biochemicals' value examination focuses on studying past and present price action to predict the probability of Krebs Biochemicals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Krebs Biochemicals' price. Additionally, you may evaluate how the addition of Krebs Biochemicals to your portfolios can decrease your overall portfolio volatility.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
CEOs Directory
Screen CEOs from public companies around the world